(62) found that Treg cell-derived IL-10 and IL-35 in the immune microenvironment against non-small cell lung cancer promoted BLIMP1-dependent CD8+ TILs depletion through a mouse model, and this synergistic effect limited effective antitumor immune potency. Here, IL10 is linked to non-small cell lung carcinoma.